EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cognitive Impairment in Tuberculous Meningitis

Angharad G Davis iD, Anna J Dreyer, Christine Albertyn, Mpumi Maxebengula, Cari Stek, Sean Wasserman, Suzaan Marais, Kathleen Bateman, Mark Solms, John Joska, Robert J Wilkinson, Sam Nightingale

Clinical Infectious Diseases · 04.03.2023 · 76 (5) · 842-849

DOI: 10.1093/cid/ciac831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 20.10.2022. Verfasst von Angharad G Davis und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Francis Crick Institute, London, United Kingdom. Hauptthemen laut MEDLINE: Tuberculosis, Meningeal, HIV Infections, Cognitive Dysfunction. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, UKRI, CRUK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cognitive impairment is reported as a common complication in adult tuberculous meningitis (TBM), yet few studies have systematically assessed the frequency and nature of impairment. Moreover, the impact of impairment on functioning and medication adherence has not been described.

Methods

A cognitive test battery (10 measures assessing 7 cognitive domains) was administered to 34 participants with human immunodeficiency virus (HIV)–associated TBM 6 months after diagnosis. Cognitive performance was compared with that a comparator group of 66 people with HIV without a history of tuberculosis. A secondary comparison was made between participants with TBM and 26 participants with HIV 6 months after diagnosis of tuberculosis outside the central nervous system (CNS). Impact on functioning was evaluated, including through assessment of medication adherence.

Results

Of 34 participants with TBM, 16 (47%) had low performance on cognitive testing. Cognition was impaired across all domains. Global cognitive performance was significantly lower in participants with TBM than in people with HIV (mean T score, 41 vs 48, respectively; P < .001). These participants also had lower global cognition scores than those with non-CNS tuberculosis (mean global T score, 41 vs 46; P = .02). Functional outcomes were not significantly correlated with cognitive performance in the subgroup of participants in whom this was assessed (n = 19).

Conclusions

Low cognitive performance following HIV-associated TBM is common. This effect is independent of, and additional to, effects of HIV and non-CNS tuberculosis disease. Further studies are needed to understand longer-term outcomes, clarify the association with treatment adherence, a key predictor of outcome in TBM, and develop context-specific tools to identify individuals with cognitive difficulties in order to improve outcomes in TBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, MeningealHIV InfectionsCognitive DysfunctionAdultHumans

Stichwörter der Autor:innen

HIVcognitive impairmentfunctional impairmenttreatment adherencetuberculous meningitis

Autor:innen und Institutionen

  • The Francis Crick Institute, London, United Kingdom.
  • Faculty of Life Sciences, University College London, London, United Kingdom.
  • Wellcome Centre for Infectious Diseases Research in Africa and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, Republic of South Africa.
  • Division of Neuropsychiatry, Department of Psychiatry and Mental Health, HIV Mental Health Research Unit, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
  • Division of Neurology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.
  • Division of Neurology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

ORCID-Profile: Angharad G Davis

Förderung

  • Wellcome Trust
  • UKRI
  • CRUK
  • NIAID NIH HHS
  • Meningitis Now
  • National Institutes of Health
  • Medical Research Council
  • Newton Fund

Zitieren

APA

Davis, A. G., Dreyer, A. J., Albertyn, C., Maxebengula, M., Stek, C., Wasserman, S., Marais, S., Bateman, K., Solms, M., Joska, J., Wilkinson, R. J., & Nightingale, S. (2023). Cognitive Impairment in Tuberculous Meningitis. Clinical Infectious Diseases, 76(5), 842-849. https://doi.org/10.1093/cid/ciac831

Vancouver

Davis AG, Dreyer AJ, Albertyn C, Maxebengula M, Stek C, Wasserman S, et al. Cognitive Impairment in Tuberculous Meningitis. Clinical Infectious Diseases. 2023;76(5):842-849. doi:10.1093/cid/ciac831

BibTeX
@article{Davis2023,
  author = {Davis, Angharad G and Dreyer, Anna J and Albertyn, Christine and Maxebengula, Mpumi and Stek, Cari and Wasserman, Sean and Marais, Suzaan and Bateman, Kathleen and Solms, Mark and Joska, John and Wilkinson, Robert J and Nightingale, Sam},
  title = {Cognitive Impairment in Tuberculous Meningitis},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {5},
  pages = {842--849},
  doi = {10.1093/cid/ciac831}
}
Kostenlos starten →